Ilvico Respir (Oxymetazoline Hydrochloride)

Oxymetazoline is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it activates alpha‑1 receptors, causing the blood vessels to constrict. This vasoconstriction reduces swelling and fluid buildup, allowing the airway to open and easing the feeling of a blocked nose.

The exact dosing regimen is set by the prescribing healthcare professional. For most OTC products, the label advises one spray per nostril every 10‑12 hours, not exceeding two doses in a 24‑hour period, but the prescriber may adjust the frequency based on individual needs.

The safety of oxymetazoline in pregnancy and lactation has not been definitively established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their doctor before using Ilvico Respir.

To place an order, submit an enquiry on the Ilvico Respir product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ilvico Respir (oxymetazoline) provides rapid, topical vasoconstriction and typically lasts up to 12 hours per dose. Compared with phenylephrine, oxymetazoline has a longer duration of action and a lower incidence of systemic side effects, while pseudo‑ephedrine works systemically and may cause more cardiovascular effects.

Store Ilvico Respir at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

Ilvico Respir is a nasal spray. The user tilts the head slightly forward, inserts the nozzle into one nostril, and depresses the pump to deliver a single spray. The same procedure is repeated in the other nostril if required, following the dosing instructions provided by the prescriber.

Serious risks include rebound nasal congestion (rhinitis medicamentosa) after prolonged use, severe hypertension, cardiac arrhythmias, and rare allergic reactions such as anaphylaxis. Patients should stop using the product if these symptoms occur and seek medical attention promptly.

Ilvico Respir should be avoided by individuals with severe hypertension, those taking monoamine oxidase inhibitors (MAOIs), or anyone who has experienced an allergic reaction to oxymetazoline or other nasal decongestants. Children under six years of age should not use the product unless specifically directed by a healthcare professional.